Rezultati - Jong‐Mu Sun

Refine Results
  1. 1
    Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherapy

    Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherap... od Jong‐Mu Sun, Joungho Han, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer

    Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer od Jong‐Mu Sun, Deok Won Hwang, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib

    Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib od Youjin Kim, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Jong‐Mu Sun

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

    Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either... od Sung Hee Lim, Ji Yun Lee, Jong‐Mu Sun, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer

    Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer od Song Ee Park, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Jong‐Mu Sun

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis

    Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis od Seonggyu Byeon, Jun Soo Ham, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab

    Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab od Yeonghee Eun, In Young Kim, Jong‐Mu Sun, Jeeyun Lee, Hoon‐Suk Cha, Eun‐Mi Koh, Hyungjin Kim, Jaejoon Lee

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient with IHC-Positive and FISH-Negative ALK

    A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient with IHC-Positive and FISH-Negative ALK od Jong‐Mu Sun, Yoon‐La Choi, Jae‐Kyung Won, Fred R. Hirsch, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park

    Izdano 2012
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non–Small-Cell Lung Cancer: A Biomarker-Stratified Randomized Phase II Trial

    Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non–Small-Cell Lung Cancer: A Biomarker-Stratified Randomize... od Jong‐Mu Sun, Jin Seok Ahn, Sin‐Ho Jung, Jiyu Sun, Sang Yun Ha, Joungho Han, Keunchil Park, Myung‐Ju Ahn

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence

    PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence od Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital

    EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital od Yoon‐La Choi, Jong-Mu Sun, Juhee Cho, Sanjay Rampal, Joungho Han, Bhash Parasuraman, Eliseo Güallar, Genehee Lee, Jeeyun Lee, Young Mog Shim

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer

    Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer od Bo Mi Ku, Yeon Hee Bae, Kyoung Young Lee, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC

    DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC od Sehhoon Park, Hayoon Lee, Boram Lee, Se‐Hoon Lee, Jong‐Mu Sun, Woong‐Yang Park, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer

    Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer od Ji Eun Shin, Hyun Ae Jung, Sehhoon Park, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Byoung Yong Shim

    Izdano 2025
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication

    Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication od Hansang Lee, Ho Yun Lee, Jong‐Mu Sun, Se‐Hoon Lee, Youjin Kim, Song Ee Park, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Genomic landscape of acquired resistance to third‐generation <i>EGFR</i> tyrosine kinase inhibitors in <i>EGFR</i> T790M‐mutant non–small cell lung cancer

    Genomic landscape of acquired resistance to third‐generation <i>EGFR</i> tyrosine kinase inhibitors in <i>EGFR</i> T790M‐mutant non–small cell lung cancer od Jiyun Lee, Hong Sook Kim, Boram Lee, Hee Kyung Kim, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Se‐Hoon Lee

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma

    The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma od Bo Mi Ku, Seong Yoon Yi, Jiae Koh, Yeon-Hee Bae, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer Patients: Impact on Survival and Correlated Prognostic Factors

    Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer Patients: Impact on Survival and Correlated Prognostic Factors od Su Jin Lee, Jung-Il Lee, Do‐Hyun Nam, Young Chan Ahn, Jung Ho Han, Jong‐Mu Sun, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma

    High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma od Bo Mi Ku, Hyun Ae Jung, Jong‐Mu Sun, Young Hyeh Ko, Han‐Sin Jeong, Young‐Ik Son, Chung‐Hwan Baek, Keunchil Park, Myung‐Ju Ahn

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC

    Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC od Youjin Kim, Boram Lee, Joonho Shim, Se‐Hoon Lee, Woong‐Yang Park, Yoon‐La Choi, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: